ArticleNature communications2025

A safe, T cell-inducing heterologous vaccine against elephant endotheliotropic herpesvirus in a proof-of-concept study.

Tanja Maehr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.